Zydus Lifesciences Limited (NSE:ZYDUSLIFE)
India · Delayed Price · Currency is INR 1,125.00
+9.90 (0.89%)
Jul 31, 2026, 3:30 PM IST
Zydus Lifesciences Market Cap
Zydus Lifesciences has a market cap or net worth of 1.12 trillion as of July 31, 2026. Its market cap has increased by 12.25% in one year.
Market Cap
1.12T
Enterprise Value
1.22T
Revenue
271.48B
Ranking
n/a
PE Ratio
22.50
Stock Price
1,125.00
ChartMarket Cap Chart
Since May 15, 2002, Zydus Lifesciences's market cap has increased from 8.20B to 1.12T, an increase of 13,614.21%. That is a compound annual growth rate of 22.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 1.12T | 22.17% |
| Dec 31, 2025 | 920.05B | -5.90% |
| Dec 31, 2024 | 977.76B | 40.16% |
| Dec 29, 2023 | 697.61B | 64.11% |
| Dec 30, 2022 | 425.08B | -14.06% |
| Dec 31, 2021 | 494.62B | 1.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.14T |
| Cipla | 1.19T |
| Mankind Pharma | 1.02T |
| Laurus Labs | 980.49B |
| Aurobindo Pharma | 909.21B |
| Alkem Laboratories | 687.68B |
| Glenmark Pharmaceuticals | 630.41B |
| Ipca Laboratories | 443.42B |